Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laxative therapy for functional abdominal pain in children
2014-005467-32Phase 4Active
- Sponsor
- HagaZiekenhuis
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of macrogol 4000 in functional abdominal pain (FAP), functional dyspepsia (FD) and Diarrhea-predominant irritable bowel syndrome (IBS-D) (2 arms), sponsored by HagaZiekenhuis. Primary endpoint: Pain-free status. Started Jul 2016; status: active.
02
Drugs
macrogol 4000
03
Conditions
functional abdominal pain (FAP)functional dyspepsia (FD)Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on 2014-005467-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005467-32.